Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Securities Class Action

Securities fraud litigation history and active cases

Active Cases

0

Pending Settlement

0

Closed

1

Total Settlement

$3M

Nabriva Therapeutics plc (NBRV) Class Action Lawsuit (December 1969)Closed

1:19cv4183 • May 8, 2019

Class Period Start

January 4, 2019

Class Period End

April 30, 2019

PSLRA Deadline

July 8, 2019

Case Allegations

10b5

Statutes of Repose

Jan 4, 2022

Country

United States

Court

Federal Court

Docket History

May 23, 2022

Disbursement Approved

May 14, 2021

Final Approval of Settlement

Feb 18, 2021

Feb 18, 2021

Proof of Claim Form

Jan 28, 2021

Preliminary Approval of Settlement

Aug 21, 2020

Scheduling Order

Aug 11, 2020

Scheduling Order

Aug 4, 2020

Scheduling Order

Jun 24, 2020

Second Amended Complaint

Jun 23, 2020

Scheduling Order

Sep 23, 2019

Sep 20, 2019

First Amended Complaint

Aug 13, 2019

Scheduling Order

Aug 1, 2019

Scheduling Order

Jul 22, 2019

Appointment of Lead Plaintiff

May 8, 2019

First Filed Complaint

TOP